colorectal cancer

Biotech

Cancer-focused Aum is latest biotech to pursue SPAC route

Aum Biosciences is merging with blank check company Mountain Crest Acquisition to put its MNK and TRK inhibitors into phase 2 testing.
James Waldron Oct 21, 2022 9:55am

Scandion flunks phase 2 test just a month after exec departures

Sep 30, 2022 3:40pm

Iterative Scopes goes a step further with FDA AI clearance

Sep 23, 2022 11:00am

Mirati posts data that mirror results reported to fanfare

Sep 8, 2022 5:15am

Owkin’s cancer-spotting AIs score European approval

Sep 6, 2022 10:11am

Celyad's CAR-T cleared by FDA in phase 1 trial, details slim

Aug 1, 2022 10:17am